Conmed [CNMD] vs Axogen [AXGN] Detailed Stock Comparison

Conmed Corporation

NYSE
Loading...

Axogen Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Conmed Corporation wins in 13 metrics, Axogen Inc. wins in 6 metrics, with 0 ties. Conmed Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Conmed Corporation Axogen Inc. Better
P/E Ratio (TTM) 25.39 -110.18 Conmed Corporation
Price-to-Book Ratio 1.15 13.15 Conmed Corporation
Debt-to-Equity Ratio 85.91 55.50 Axogen Inc.
PEG Ratio -0.50 0.04 Axogen Inc.
EV/EBITDA 10.06 -2,165.44 Conmed Corporation
Profit Margin (TTM) 3.42% -6.97% Conmed Corporation
Operating Margin (TTM) 7.25% -16.31% Conmed Corporation
EBITDA Margin (TTM) 7.25% N/A N/A
Return on Equity 4.72% -13.49% Conmed Corporation
Return on Assets (TTM) 3.47% -2.31% Conmed Corporation
Free Cash Flow (TTM) $150.88M $-4.78M Conmed Corporation
Dividend Yield 1.15% N/A N/A
1-Year Return -35.07% 341.03% Axogen Inc.
Price-to-Sales Ratio (TTM) 0.86 8.27 Conmed Corporation
Enterprise Value $2.03B $1.89B Conmed Corporation
EV/Revenue Ratio 1.48 8.40 Conmed Corporation
Gross Profit Margin (TTM) 58.49% 74.13% Axogen Inc.
Revenue per Share (TTM) $44 $5 Conmed Corporation
Earnings per Share (Diluted) $1.51 $-0.34 Conmed Corporation
Beta (Stock Volatility) 0.99 0.98 Axogen Inc.
Short % of Float 9.10% 6.92% Axogen Inc.

Conmed Corporation vs Axogen Inc. Stock Performance Analysis

Loading Price Chart...

CNMD
AXGN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Conmed Corporation-1.75%-0.96%-3.75%-8.69%-15.28%-15.70%
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Conmed Corporation-35.07%-74.37%-74.32%-19.21%30.57%82.52%
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%

Performance & Financial Health Analysis: Conmed Corporation vs Axogen Inc.

MetricCNMDAXGN
Market Information
Market Cap i$1.18B$1.94B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i360,2901,245,238
90 Day Avg. Volume i397,5671,068,353
Last Close$34.16$43.74
52 Week Range$32.13 - $56.64$9.22 - $45.83
% from 52W High-39.69%-4.56%
All-Time High$159.11 (Nov 01, 2021)$56.85 (Jul 23, 2018)
% from All-Time High-78.53%-23.06%
Growth Metrics
Quarterly Revenue Growth0.08%0.21%
Quarterly Earnings Growth-0.50%0.21%
Financial Health
Profit Margin (TTM) i0.03%-0.07%
Operating Margin (TTM) i0.07%-0.16%
Return on Equity (TTM) i0.05%-0.13%
Debt to Equity (MRQ) i85.9155.50
Cash & Liquidity
Book Value per Share (MRQ)$33.36$2.73
Cash per Share (MRQ)$1.32$0.80
Operating Cash Flow (TTM) i$170.69M$812,000
Levered Free Cash Flow (TTM) i$169.27M$3.58M
Dividends
Last 12-Month Dividend Yield i1.15%N/A
Last 12-Month Dividend i$0.60$0.00

Valuation & Enterprise Metrics Analysis: Conmed Corporation vs Axogen Inc.

MetricCNMD (Apr 26, 2026)AXGN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.39-110.18
Forward P/E i7.7847.31
PEG Ratio i-0.500.04
Price to Sales (TTM) i0.868.27
Price to Book (MRQ) i1.1513.15
Market Capitalization
Market Capitalization i$1.18B$1.94B
Enterprise Value i$2.03B$1.89B
Enterprise Value Metrics
Enterprise to Revenue i1.488.40
Enterprise to EBITDA i10.06-2,165.44
Risk & Other Metrics
Beta i0.990.98
Book Value per Share (MRQ) i$33.36$2.73

Financial Statements Comparison: Conmed Corporation vs Axogen Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCNMD (2025)AXGN (2025)
Revenue/Sales i1.37B225.21M
Cost of Goods Sold i624.25M57.86M
COGS % of Revenue i45.4%25.7%
Gross Profit i750.48M167.35M
Gross Margin i54.6%74.3%
Research & Development i55.88M32.89M
Operating Income (EBIT) i102.62M-7.85M
Operating Margin i7.5%-3.5%
EBITDA i176.49M826,000
EBITDA Margin i12.8%0.4%
Pre-Tax Income i71.12M-15.70M
Pre-Tax Income % of Revenue i5.2%-7.0%
Income Tax i24.06MN/A
Income Tax % of Revenue i1.8%0.0%
Net Income (Profit) i47.06M-15.70M
Profit Margin i3.4%-7.0%

Balance Sheet & Liquidity Metrics

MetricCNMD (2025)AXGN (2025)
Cash & Equivalents i40.82M35.55M
Total Current Assets i672.86M120.42M
Total Current Assets % of Revenue i48.9%53.5%
Total Current Liabilities i315.04M23.56M
Total Current Liabilities % of Revenue i22.9%10.5%
Long-Term Debt i834.23M65.26M
Long-Term Debt % of Revenue i60.7%29.0%
Total Shareholders Equity i1.03B128.85M
Retained Earnings i588.77M-306.96M
Retained Earnings % of Revenue i42.8%-136.3%
Property, Plant & Equipment i029.38M

Cash Flow Statement Comparison

MetricCNMD (2025)AXGN (2025)
Operating Cash Flow i155.41M10.26M
Operating Cash Flow % of Revenue i11.3%4.6%
Capital Expenditures i-19.81M-3.75M
Free Cash Flow i150.88M-4.78M
FCF Margin i11.0%-2.1%
Debt Repayment i-795.25M-32,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCNMDAXGN
Shares Short i2.31M3.50M
Short Ratio i5.604.04
Short % of Float i9.10%6.92%
Shares Outstanding i30.97M47.20M
Float Shares i30.54M50.75M
% Held by Insiders i0.41%2.12%
% Held by Institutions i113.93%88.11%
% Held by Public i-14.34%9.77%

Dividend Analysis & Yield Comparison: Conmed Corporation vs Axogen Inc.

MetricCNMDAXGN
Last 12-Month Dividend i$0.60$0.00
Last 12-Month Dividend Yield i1.15%N/A
3-Year Avg Annual Dividend i$0.73$0.00
3-Year Avg Dividend Yield i0.24%N/A
3-Year Total Dividends i$2.20$0.00
Ex-Dividend DateMar 14, 2025N/A